SHAREHOLDER ALERT:  Brodsky & Smith, LLC Announces an Investigation  of  The Board of Directors of ZELTIQ Aesthetics, Inc. -ZLTQ


BALA CYNWYD, February 17, 2017 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ZELTIQ Aesthetics, Inc. (“ZELTIQ” or “the Company”) (Nasdaq- ZLTQ-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Allergan plc. (“Allergan”).

Under the terms of the transaction, ZELTIQ common shareholders will receive only $56.50 in cash for each share of ZELTIQ stock they own. The investigation concerns whether the Board of  ZELTIQ breached their fiduciary duties to shareholders and whether Allergan is underpaying for the Company. The transaction may undervalue the Company given that on January 26, 2017, the Company announced the FDA clearance of CoolSculpting. This, proprietary controlled-cooling technology, is the only product of its kind on the market for the non-invasive treatment of fat in the upper arms. As a result, Allegan anticipates gaining significant cross-selling opportunities from this acquisition. Consequently, the investigation seeks to determine if a fair price for ZELTIQ would have been at or above an analyst price target of $58.00 per share

If you own shares of ZELTIQ stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, or calling toll  free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.